C D Steward
Overview
Explore the profile of C D Steward including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naimi T, LeDell K, Boxrud D, Groom A, Steward C, Johnson S, et al.
Clin Infect Dis
. 2001 Aug;
33(7):990-6.
PMID: 11528570
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged among patients in the general population who do not have established risk factors for MRSA. Records from 10 Minnesota health facilities were reviewed to...
2.
Steward C, Rasheed J, Hubert S, Biddle J, Raney P, Anderson G, et al.
J Clin Microbiol
. 2001 Jul;
39(8):2864-72.
PMID: 11474005
Extended-spectrum beta-lactamases (ESBLs) are enzymes found in gram-negative bacilli that mediate resistance to extended-spectrum cephalosporins and aztreonam. In 1999, the National Committee for Clinical Laboratory Standards (NCCLS) published methods for...
3.
Yigit H, Queenan A, Anderson G, Domenech-Sanchez A, Biddle J, Steward C, et al.
Antimicrob Agents Chemother
. 2001 Mar;
45(4):1151-61.
PMID: 11257029
A Klebsiella pneumoniae isolate showing moderate to high-level imipenem and meropenem resistance was investigated. The MICs of both drugs were 16 microg/ml. The beta-lactamase activity against imipenem and meropenem was...
4.
Steward C, Wallace D, Hubert S, Lawton R, Fridkin S, Gaynes R, et al.
Diagn Microbiol Infect Dis
. 2000 Oct;
38(1):59-67.
PMID: 11025185
A proficiency testing project was conducted among 48 microbiology laboratories participating in Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology). All laboratories correctly identified the Staphylococcus aureus challenge strain as oxacillin-...
5.
Fridkin S, Steward C, Edwards J, Pryor E, McGowan Jr J, Archibald L, et al.
Clin Infect Dis
. 1999 Sep;
29(2):245-52.
PMID: 10476720
The search for the means to understand and control the emergence and spread of antimicrobial resistance has become a public health priority. Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology) has...
6.
Steward C, Stocker S, Swenson J, OHara C, Edwards J, Gaynes R, et al.
J Clin Microbiol
. 1999 Feb;
37(3):544-7.
PMID: 9986809
Fluoroquinolone resistance appears to be increasing in many species of bacteria, particularly in those causing nosocomial infections. However, the accuracy of some antimicrobial susceptibility testing methods for detecting fluoroquinolone resistance...
7.
Weigel L, Steward C, Tenover F
Antimicrob Agents Chemother
. 1998 Oct;
42(10):2661-7.
PMID: 9756773
Fluoroquinolone resistance (FQ-R) in clinical isolates of Enterobacteriaceae species has been reported with increasing frequency in recent years. Two mechanisms of FQ-R have been identified in gram-negative organisms: mutations in...
8.
OHara C, Steward C, Wright J, Tenover F, Miller J
J Clin Microbiol
. 1998 Sep;
36(10):3055-6.
PMID: 9738068
We describe the isolation and identification of Enterobacter intermedium from the gallbladder of a patient with cholecystitis. There have been only four documented isolations of this organism from humans; it...
9.
Tenover F, Lancaster M, Hill B, Steward C, Stocker S, Hancock G, et al.
J Clin Microbiol
. 1998 May;
36(4):1020-7.
PMID: 9542929
During the last several years a series of staphylococcal isolates that demonstrated reduced susceptibility to vancomycin or other glycopeptides have been reported. We selected 12 isolates of staphylococci for which...